Zephyr® Endobronchial Valves

September 8, 2016September 8, 2016

New Lung Analysis Platform Rapidly Identifies Patients Eligible for Endobronchial Valve Treatment

Emphysema, News

Pulmonx recently announced that its StratX Lung Analysis Platform is commercially available in countries requiring CE mark (Conformité Européne, a mark that proves a product complies with the essential requirements ... Read more

May 20, 2016May 20, 2016

Follow-up Data from Study of EBV Treatment in Emphysema Patients Shows Lasting Benefits

Emphysema, News

Pulmonx Corporation reported positive one-year data from the STELVIO trial, the first randomized study evaluating the Zephyr Endobronchial Valve (EBV) in people with severe emphysema, who were selected using the diagnostic Chartis System to identify ... Read more